Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin in Alzheimer's Disease
NCT00432081Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Indomethacin with Placebo (2 arms). Primary endpoint: Alzheimer's Disease Assessment Scale - Cognitive Subscale at 12 months. Started May 2000; status: completed.
02
Drugs
indomethacin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00432081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432081.